SkyCell

PharmaLifeScience News

...

Starboard accuses Pfizer management of $20bn value destruction
Activist investor with $1bn stake says leaders should be held responsible for inadequate returns
READ MORE
...

Europe's share of clinical trials falling, with China rising
Europe's share of clinical trials falling, with China risingPhil.TaylorTue, 22/10/2024 - 09:41Bookmark thisPhil.TaylorTue, 22/10/2024 - 09:41Bookmark this
READ MORE
...

New 4.5m initiative launched to address UK medicines manufacturing skills shortage
The two-year programme will use virtual reality technology to teach essential skills
READ MORE

Ocuphire and Opus Genetics merge to develop IRD gene therapy

Investors and big pharma no longer avoiding techbio companies

Lexicon partners Viatris for global expansion of sotagliflozin

US Elections: how healthcare could look under a Harris or Trump administration

BenevolentAI CEO steps down as founders make a comeback

Influencing the future of healthcare communications

Targeting Fat Metabolism Enhances Ferroptosis-Inducing Cancer Treatments

Sage cuts a third of its workforce after R&D setbacks

Seaport docks $225m for its improved neuropsychiatry drugs

The future of UK life sciences starts in the West Midlands

Precision, planning and creativity for launch excellence in a volatile sector

Opioid addiction market to reach $2.4 billion across 8MM by 2033

Lundbeck initiates clinical trial in Thyroid Eye Disease

Joyce Fitzharris is the new chair of BioPharmaChem Ireland

Harnessing the power of upstream platform integration to accelerate biopharma innovation

Otsuka eyes early filing of IgAN drug after phase 3 readout

Darzalex subcutaneous regimen approved by European Commission

Eli Lilly appoints new chief AI officer

Cereno Scientific strengthen its focus on rare diseases

Unlocking impact and growth at times of demerger

New Insights into SARS-CoV-2’s Evasion of Innate Immunity
Ellab